[cc439]

Medicare for all would do nothing to harm Big Pharma as the government is not legally allowed to use its monopsony status to negotiate prices under Medicare Part D (the section of Medicare that accounts for 85% of government drug spending). If anything, it would be a boon to Big Pharma as it removes barriers to access for an enormous number of new "customers". Interestingly, it was the Trump administration [1] who made the first move to allow the government to negotiate drug prices by loosening the restrictions against such practices for Medicare Part B spending (which represents 15% of government drug spending). I'm not saying the American right wing's approach is in any way comparable to the left's, I'm just saying that the left's approach suspiciously overlooks any solutions that might actually threaten Big Pharma.

[1]: https://www.bloomberg.com/news/articles/2018-08-07/trump-for...

[zrail]

The M4A bills that are working their way through Congress right now all remove that restriction.